Press release
Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2%
The global insomnia treatment market is expected to be worth US$ 6,886.1 million in 2024. The market is anticipated to expand at a CAGR of 5.2% from 2024 to 2034. The market is predicted to reach US$ 11,385.5 million in 2034. Increasing awareness and understanding of the condition among patients and healthcare professionals is one of the key drivers of the insomnia treatment industry.As more people come to recognize the impact that insomnia has on their daily lives, they are seeking out treatments to help manage their symptoms. Additionally, advances in medical research and technology have led to the development of more effective and targeted treatments for insomnia. This has allowed healthcare providers to offer patients a wider range of options for managing their condition, from medication to behavioral therapies.
The changes in lifestyle and work patterns have contributed to the rise of insomnia, as many people find themselves struggling to balance their responsibilities with the need for restful sleep. As such, there is a growing need for effective and accessible treatments to help people manage their insomnia and improve their overall quality of life.
For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=9613
Key Market Drivers
Rising Prevalence of Sleep Disorders: Lifestyle changes, increased stress levels, and work-related pressures have contributed to a surge in insomnia cases globally. As more individuals recognize the importance of quality sleep, the demand for treatment options has escalated .
Advancements in Therapeutic Options: The development of novel pharmacological treatments, such as dual orexin receptor antagonists, offers more targeted and effective solutions for insomnia with fewer side effects compared to traditional sedatives .
Growth of Over-the-Counter (OTC) Medications: OTC drugs are gaining popularity due to their accessibility and cost-effectiveness. In 2024, OTC drugs are expected to account for a significant share of the market, driven by consumer preference for easily obtainable sleep aids .
Regional Insights
North America: This region holds a substantial share of the insomnia treatment market, attributed to high awareness levels, robust healthcare infrastructure, and the adoption of digital health tools. The U.S., in particular, faces a significant economic burden due to inadequate sleep, emphasizing the need for effective treatment options .
Asia-Pacific: Countries like India, China, and Japan are experiencing rapid growth in the insomnia treatment market. Factors such as urbanization, increased screen time, and rising mental health concerns contribute to this trend. In India, for instance, the market is expected to grow at a CAGR of 2.57% from 2025 to 2033, driven by increased stress levels and growing awareness about sleep disorders .
Emerging Trends
Digital Therapeutics: The integration of digital solutions, such as mobile applications and wearable devices, is revolutionizing insomnia treatment. These tools offer personalized therapy options, including cognitive behavioral therapy for insomnia (CBT-I), and have shown a 70% success rate in improving sleep quality
Non-Pharmacological Treatments: There's a growing preference for non-drug therapies, including CBT and relaxation techniques, due to concerns over the side effects of long-term medication use. These approaches are gaining traction as effective alternatives for managing insomnia .
Challenges
Despite the positive outlook, the market faces challenges such as side effects associated with certain insomnia medications, which can hamper long-term treatment adherence. Additionally, the need for more personalized treatment approaches remains a critical area for development.
Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=9613
Conclusion
The insomnia treatment market is undergoing significant transformation, driven by increased awareness, technological advancements, and a shift towards personalized and non-pharmacological therapies. As the understanding of sleep disorders deepens, the market is expected to continue its growth trajectory, offering diverse and effective treatment options for individuals worldwide.
Explore More Related Studies Published by Fact.MR Research:
Dental Infection Control Products Market
https://www.factmr.com/report/5378/dental-infection-control-products-market
Air Ambulance Services Market
https://www.factmr.com/report/air-ambulance-services-market
Neonatal Ventilator Market
https://www.factmr.com/report/758/neonatal-ventilator-market
Dental 3D Printing Market
https://www.factmr.com/report/4361/dental-3d-printing-market
Joint Reconstruction Devices Market
https://www.factmr.com/report/joint-reconstruction-devices-market
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
About Fact.MR:
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2% here
News-ID: 4033872 • Views: …
More Releases from FactMR
Medical Coatings Market to Hit USD 14,344.1 million by 2035- Growth Accelerates …
The global medical coatings market is set for sustained growth through 2035, powered by minimally invasive procedures, infection prevention priorities, and smart biocompatible innovations. According to Future Market Insights (FMI), the market is valued at USD 5,683.4 million in 2025 and is projected to reach USD 14,344.1 million by 2035, expanding at a compound annual growth rate (CAGR) of 9.7%.
The FMI report, "Medical Coatings Market Size, Share, and Forecast 2025-2035,"…
Modular Energy Control System Market to Hit USD 10,400 million by 2035- Growth A …
The global modular energy control system market is set for robust expansion through 2035, fueled by scalable infrastructure, real-time optimization, and seamless renewable energy integration. According to Future Market Insights (FMI), the market is valued at USD 4,600 million in 2025 and is projected to reach USD 10,400 million by 2035, expanding at a compound annual growth rate (CAGR) of 8.4%
The FMI report, "Modular Energy Control System Market Size, Share,…
Airborne Warning and Control System Market to Surpass USD 11,888.1 million by 20 …
The global airborne warning and control system (AWACS) market is accelerating toward a decade of robust expansion, driven by escalating geopolitical tensions, defense modernization, and AI-enhanced threat detection. According to Future Market Insights (FMI), the market is valued at USD 5,209.7 million in 2025 and is projected to reach USD 11,888.1 million by 2035, growing at a compound annual growth rate (CAGR) of 8.6%.
The FMI report, "Airborne Warning and Control…
N-Ethyl-2-Pyrrolidone Market to Reach USD 2.35 million by 2035- Steady Growth Le …
The global N-Ethyl-2-Pyrrolidone (NEP) market is poised for consistent expansion through 2035, fueled by rising demand in high-purity electronics, lithium-ion battery production, and pharmaceutical synthesis. According to Future Market Insights (FMI), the market is valued at USD 1.39 million in 2025 and is projected to hit USD 2.35 million by 2035, growing at a compound annual growth rate (CAGR) of 5.4%.
The FMI report, "N-Ethyl-2-Pyrrolidone Market Size, Share, and Forecast 2025-2035,"…
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…
